Skip to main content
. 2009 Summer;20(2):e19–e23. doi: 10.1155/2009/641941

TABLE 1.

Frequencies and ORs of hepatitis C virus (HCV) test results (by patient characteristics) of the cohort receiving hemodialysis on the implicated brand of machines between December 2003 and June 2004

Total (n=1286) Anti-HCV and/or HCV-PCR
OR 95% CI P
Positive (n=69) Negative (n=1217)
Sex, n (%)
  Men 764 (59.4) 48 (6.3) 716 (93.7) 1.00
  Women 522 (40.6) 21 (4.0) 501 (96.0) 0.63 0.37–1.06 0.08
Mean age ± SD, years 63.1±15.8 52.8±11.9 63.7±15.8 0.96 0.95–0.98 <0.01
Health authority, n (%)
  Interior 123 (9.6) 6 (4.9) 117 (95.1) 0.97 0.39–2.42 0.96
  Fraser 520 (40.7) 26 (5.0) 494 (95.0) 1.00
Vancouver Coastal 213 (16.7) 10 (4.7) 203 (95.3) 0.94 0.44–1.98 0.86
Vancouver Island 314 (24.6) 21 (6.7) 293 (93.3) 1.36 0.75–2.46 0.31
  Northern 108 (8.5) 5 (4.6) 103 (95.4) 0.92 0.35–2.46 0.87
Time on dialysis, n (%)
  <2 years 578 (44.9) 30 (5.2) 548 (94.8) 1.00
  2–4 years 576 (44.8) 32 (5.6) 544 (94.4) 1.08 0.64–1.79 0.78
  ≥ 5 years 132 (10.3) 7 (5.3) 125 (94.7) 1.02 0.44–2.38 0.96
Transplant, n (%)
  Yes 144 (11.2) 13 (9.0) 131 (91.0) 1.92 1.03–3.61 0.04
  No 1142 (88.8) 56 (4.9) 1086 (95.1) 1.00

PCR Polymerase chain reaction